首页> 美国卫生研究院文献>Scientific Reports >Complex Hydrogels Composed of Chitosan with Ring-opened Polyvinyl Pyrrolidone as a Gastroretentive Drug Dosage Form to Enhance the Bioavailability of Bisphosphonates
【2h】

Complex Hydrogels Composed of Chitosan with Ring-opened Polyvinyl Pyrrolidone as a Gastroretentive Drug Dosage Form to Enhance the Bioavailability of Bisphosphonates

机译:壳聚糖与开环聚乙烯吡咯烷酮作为胃滞留药物剂型的复合水凝胶可增强双膦酸盐的生物利用度

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Complex hydrogels formed with chitosan (CS) and ring-opened polyvinyl pyrrolidone (roPVP) as a swellable mucoadhesive gastroretentive drug dosage form (smGRDDF) were prepared and characterized. CS/roPVP hydrogels were produced by blending CS with roPVP obtained by basic treatment of PVP. Effects of the heating time and NaOH concentration employed for preparing roPVP, and CS molecular weights (Mws), and roPVP/CS ratios on the swelling ability of the resultant hydrogels were characterized. Rheological characteristics were further examined. Results demonstrated that roPVP obtained in a 0.5 M NaOH solution heated to 50 °C for 4 h was suitable for producing complex hydrogels with CS. At a roPVP/CS ratio of 20:1, hydrogels composed of three different Mws of CS possessed optimal swelling and mucoadhesive abilities and rheological properties. In vitro dissolution revealed sustained drug release. A pharmacokinetic study exhibited that the plasma profile of alendronate followed a sustained manner with 3-fold enhancement of the oral bioavailability. In conclusion, the smGRDDF composed of CS/roPVP complex hydrogels was successfully developed and is potentially applicable to improve the clinical efficacy of bisphosphonates.
机译:制备并表征了由壳聚糖(CS)和开环聚乙烯吡咯烷酮(roPVP)作为可溶性粘膜粘附性胃滞留药物剂型(smGRDDF)形成的复合水凝胶。 CS / roPVP水凝胶是通过将CS与通过PVP基本处理而获得的roPVP混合制得的。表征了用于制备roPVP的加热时间和NaOH浓度,CS分子量(Mws)以及roPVP / CS比对所得水凝胶溶胀能力的影响。流变特性被进一步检查。结果表明,在0.5 M NaOH溶液中加热到50 C持续4 h所获得的roPVP适用于制备具有CS的复合水凝胶。当roPVP / CS比率为20:1时,由三种不同分子量的CS组成的水凝胶具有最佳的溶胀和粘膜粘附能力以及流变特性。体外溶解显示药物持续释放。药代动力学研究表明,阿仑膦酸盐的血浆分布遵循持续的方式,口服生物利用度提高了3倍。总而言之,由CS / roPVP复合水凝胶组成的smGRDDF已成功开发,并且可能适用于提高双膦酸盐的临床疗效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号